366 related articles for article (PubMed ID: 28901267)
1. Therapeutic Drug Monitoring in Pediatric IBD: Current Application and Future Perspectives.
Lega S; Bramuzzo M; Dubinsky MC
Curr Med Chem; 2018; 25(24):2840-2854. PubMed ID: 28901267
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease.
Carman N; Mack DR; Benchimol EI
Curr Gastroenterol Rep; 2018 Apr; 20(5):18. PubMed ID: 29623442
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Drug Monitoring of Biologics for Inflammatory Bowel Disease: An Answer to Optimized Treatment?
Hoseyni H; Xu Y; Zhou H
J Clin Pharmacol; 2018 Jul; 58(7):864-876. PubMed ID: 29462502
[TBL] [Abstract][Full Text] [Related]
4. Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.
Papamichael K; Cheifetz AS; Melmed GY; Irving PM; Vande Casteele N; Kozuch PL; Raffals LE; Baidoo L; Bressler B; Devlin SM; Jones J; Kaplan GG; Sparrow MP; Velayos FS; Ullman T; Siegel CA
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1655-1668.e3. PubMed ID: 30928454
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Drug Monitoring of Biologics for Patients with Inflammatory Bowel Diseases: How, When, and for Whom?
Wu JF
Gut Liver; 2022 Jul; 16(4):515-524. PubMed ID: 34670875
[TBL] [Abstract][Full Text] [Related]
6. Wide variation in the use and understanding of therapeutic drug monitoring for anti-TNF agents in inflammatory bowel disease: an inexact science?
Samaan MA; Arkir Z; Ahmad T; Irving PM
Expert Opin Biol Ther; 2018 Dec; 18(12):1271-1279. PubMed ID: 30339466
[TBL] [Abstract][Full Text] [Related]
7. Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.
Mitrev N; Vande Casteele N; Seow CH; Andrews JM; Connor SJ; Moore GT; Barclay M; Begun J; Bryant R; Chan W; Corte C; Ghaly S; Lemberg DA; Kariyawasam V; Lewindon P; Martin J; Mountifield R; Radford-Smith G; Slobodian P; Sparrow M; Toong C; van Langenberg D; Ward MG; Leong RW;
Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1037-1053. PubMed ID: 29027257
[TBL] [Abstract][Full Text] [Related]
8. Precision Dosing of Anti-TNF Therapy in Pediatric Inflammatory Bowel Disease.
Samuels A; Whaley KG; Minar P
Curr Gastroenterol Rep; 2023 Nov; 25(11):323-332. PubMed ID: 37695555
[TBL] [Abstract][Full Text] [Related]
9. A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease.
Cheifetz AS; Abreu MT; Afif W; Cross RK; Dubinsky MC; Loftus EV; Osterman MT; Saroufim A; Siegel CA; Yarur AJ; Melmed GY; Papamichael K
Am J Gastroenterol; 2021 Oct; 116(10):2014-2025. PubMed ID: 34388143
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic drug monitoring in patients on biologics: lessons from gastroenterology.
Papamichael K; Cheifetz AS
Curr Opin Rheumatol; 2020 Jul; 32(4):371-379. PubMed ID: 32412995
[TBL] [Abstract][Full Text] [Related]
11. Challenges in Therapeutic Drug Monitoring: Optimizing Biological Treatments in Patients With Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases.
Papamichael K; Stocco G; Ruiz Del Agua A
Ther Drug Monit; 2023 Oct; 45(5):579-590. PubMed ID: 37012629
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring in inflammatory bowel disease: for every patient and every drug?
Papamichael K; Cheifetz AS
Curr Opin Gastroenterol; 2019 Jul; 35(4):302-310. PubMed ID: 30973355
[TBL] [Abstract][Full Text] [Related]
13. Anti-Tumor Necrosis Factor Alpha Therapeutic Drug Monitoring in Inflammatory Disease: A Systematic Review.
Schneider C; Stratman S; Choragudi S; Lev-Tov H
J Drugs Dermatol; 2023 May; 22(5):445-450. PubMed ID: 37133467
[TBL] [Abstract][Full Text] [Related]
14. New Zealand Society of Gastroenterology Guidelines on Therapeutic Drug Monitoring in Inflammatory Bowel Disease.
Khan A; Berahmana AB; Day AS; Barclay ML; Schultz M
N Z Med J; 2019 Mar; 132(1491):46-62. PubMed ID: 30845128
[TBL] [Abstract][Full Text] [Related]
15. Clinical Pharmacology in Adult and Pediatric Inflammatory Bowel Disease.
Hemperly A; Sandborn WJ; Vande Casteele N
Inflamm Bowel Dis; 2018 Nov; 24(12):2527-2542. PubMed ID: 29788338
[TBL] [Abstract][Full Text] [Related]
16. American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases.
Vande Casteele N; Herfarth H; Katz J; Falck-Ytter Y; Singh S
Gastroenterology; 2017 Sep; 153(3):835-857.e6. PubMed ID: 28774547
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of therapeutic drug monitoring in inflammatory bowel disease.
McNeill RP; Barclay ML
Curr Opin Pharmacol; 2020 Dec; 55():41-46. PubMed ID: 33120169
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring in inflammatory bowel disease: The dawn of reactive monitoring.
Albader F; Golovics PA; Gonczi L; Bessissow T; Afif W; Lakatos PL
World J Gastroenterol; 2021 Oct; 27(37):6231-6247. PubMed ID: 34712029
[TBL] [Abstract][Full Text] [Related]
19. Current Practices for Therapeutic Drug Monitoring of Biopharmaceuticals in Pediatrics.
Murias S; Magallares L; Albizuri F; Pascual-Salcedo D; Dreesen E; Mulleman D
Ther Drug Monit; 2017 Aug; 39(4):370-378. PubMed ID: 28703718
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic drug monitoring-based dosing of TNF inhibitors in inflammatory bowel disease: the way forward?
Strik AS; Berends SE; Löwenberg M
Expert Rev Clin Pharmacol; 2019 Sep; 12(9):885-891. PubMed ID: 31305158
[No Abstract] [Full Text] [Related]
[Next] [New Search]
